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Objective: Between 60% and 70% of people with epilepsy become seizure free and
may choose to withdraw from antiepileptic medication. Numerous studies discuss
possible factors which may influence seizure recurrence following discontinuation.
However, few studies attempt to explore the decision-making process from the
perspective of the patient. It is believed this is the first study to explore patients’
experience of discontinuing medication following a seizure-free period of 2 years.
Method: Semi-structured interviews were conducted with twelve people with epi-
lepsy who had attempted withdrawal from their medication. All twelve of the
participants lived in the North-East of England. A phenomenological approach was
taken in order to gain an in depth understanding of their withdrawal decisions.
Results: Five themes emerged from the interviews. Principally, the timing of when to
withdraw was a key concern, as well as the uncertainty of seizure recurrence, issues
with medication and the embarrassment of being diagnosed with epilepsy. Those who
unsuccessfully withdrew from medication discussed their acceptance of the condi-
tion. Mixed feelings regarding satisfaction with G.P. support were also reported.
Conclusions: Incorporating the themes into the Theory of Planned Behaviour [Ajzen I.
In: Marks DF, editor. The health psychology reader. London: Sage; 1985] provides a
model of the withdrawal decision-making process based on the experiences of those
who have made the decision. There is a paucity of research investigating the with-
drawal decision, therefore the findings from this study should be used for the
production of appropriate and relevant information regarding the key issues which
have been raised regarding withdrawal decisions and support those making the
decision.
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Although epilepsy is a chronic neurological condi-
tion, 60—70% of people with the condition may. Published by Elsevier Ltd. All rights reserved.
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with the decision to withdraw from their antiepi-
leptic drugs (AEDs).1 Numerous reports highlight the
side effects of AEDs, such as fatigue and drowsiness2
and impaired cognitive function.3 With the emer-
gence of evidence for the reversal of such effects
following discontinuation, the issue of supporting
people in the withdrawal decision becomes para-
mount.
A limited number of studies have explored the
psychological impact of withdrawal from AEDs, but
not the decision-making process. Baker4 conducted
a withdrawal study and found that 2 years following
AED withdrawal, there were no significant psycho-
social problems evident in the study sample.
Furthermore, it has been found that discontinuation
of AED treatment can lead to an increase in self-
esteem, and a reduction in feelings of stigma.5
Therefore, it appears that problems associated with
having epilepsymay be reduced through a successful
discontinuation of the treatment.
Within the withdrawal literature there is a pre-
dominance of research exploring prediction of sei-
zure recurrence following AED discontinuation in an
attempt to better inform and counsel peoplemaking
the decision. However, no firm conclusions regarding
how to predict relapse have yet been drawn from
these studies. Berg and Shinar6 note a 10—70%
relapse rate cited across the literature and more
recently research has identified relapse rates of 31%
for children7 while others cite 10%.8
There are numerous problems that may account
for this discrepancy in relapse rates. In general the
literature suffers from a wide variation in methodol-
ogies employed such as, the type of epilepsy
explored, prognostic factors used, length of fol-
low-up, randomisation procedures and age at diag-
nosis and withdrawal. Furthermore, a report in
Frankel9 argued there are more psychological impli-
cations which should be taken into account in the
decision-making process rather than just the phy-
siological issues.
Interestingly, The Medical Research Council Anti-
epileptic Drug Withdrawal Study Group10 found non-
randomisation into a withdrawal group centred
around the participant not wanting to lose his/her
driving license. This highlights additional concerns
in the decision-making process to seizure recur-
rence. Furthermore, Aktekin et al.7 argue people
contemplating withdrawal from AEDs should get
support from their physicians regarding the social
consequences of discontinuing their medication.
Jacoby et al.5 and Perucca et al.2 argue that
doctors should help counsel those who are eligible
for AED withdrawal, and in particular, focus on the
psychosocial implications of their decision. How-ever, there is evidence to suggest that no such
support is provided. For example, The Medical
Research Council10 asserts that in the UK, epilepsy
sufferers who are in long term remission receive
very little (if any) medical advice from their doc-
tors. In addition, Chappell11 reports that epilepsy
sufferers often feel they are expected to ‘‘experi-
ment’’ with their medication, and stop or reduce it
themselves. Clearly this is an area that needs
greater attention and research focus.
In summary, although no psychosocial problems
have been found following withdrawal from AED
treatment,4 the psychological factors considered
while making the decision are not known. The
majority of research in this area concentrates on
predicting seizure recurrence, yet the inaccuracy of
current methods and the overlooking of psychoso-
cial considerations means the support provided by
physicians in the decision-making process could be
inadequate. By determining what is of importance
to people with epilepsy when making the withdra-
wal decision, suggestions could bemade as to how to
provide adequate health services to support them in
making the decision.
A key model of decision-making is the Theory of
Planned Behaviour,12 the strengths of which lie in its
consideration of social beliefs and perceptions
regarding behaviour, as well as cognitions and atti-
tudes towards a behaviour. As psychosocial issues
have been noted as concerns within the AED with-
drawal process, although not adequately investi-
gated to date, it would be interesting to explore
if the findings from the current study could be
incorporated into the Theory of Planned Behaviour
in order to provide a clear model of the withdrawal
decision-making process. Such a model could ulti-
mately be used to direct support for people making
the withdrawal decision.
The paucity of research regarding the experience
of discontinuing treatment means it would be diffi-
cult to develop a reliable questionnaire to address
these issues. Consequently a phenomenological
approach has been adopted in the current study.
Phenomenological research aims to identify the
‘‘lived experience’’ of a phenomena,13 and will
concentrate on investigating the subjective ‘‘rea-
lity’’ of discontinuing AED medication.14
Scambler15 argues that experiential knowledge of
epilepsy (i.e. the exploration of the phenomenon of
epilepsy from the patient’s point of view) is impor-
tant to explore in order to ensure patient needs are
adequately addressed. This paper aims to explore the
meaning and experience of withdrawing from AED
treatment following a 2-year seizure-free period and
the process of making the withdrawal decision. In
turn, it may be possible to identify ways in which
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counsel those making the withdrawal decision.Method
Design
A qualitative approach using semi-structured inter-
views with open questions was used. In accordance
with guidelines proposed by Husserl and In Byrne,16
bracketing was used before and during the inter-
views in order to ensure that any preconceptions or
biases regarding epilepsy were acknowledged by the
researchers and would not affect the interpretation
of the results. For example, when designing the
questions, care was taken so that the background
research did not influence the types of questions
asked, which in turn may have biased and restricted
the responses of the participants.
Participants
Twelve participants were recruited, five of whom
were male and seven female, with an age range of
15—56 years. The person with epilepsy was inter-
viewed in all cases except for the 15 year old who’s
parentswished to takepart in the interview.Theyhad
allbeen seizure free forat least2 yearsbeforemaking
the decision to discontinue AED treatment and were
either making the decision to withdraw from treat-
ment at that time, or had already withdrawn from
treatment. One of the participants was making the
withdrawal decision at the time of the interview;
seven had successfully withdrawn from their AED
medication at the first attempt (they had not experi-
enced a seizure since discontinuing their medica-
tion); three had successfully withdrawn following a
second attempt; and one participant had not been
successful after three failed withdrawal attempts.
The participants were recruited via epilepsy sup-
port groups in the North East of England. Once
ethical permission had been obtained, support
group leaders across the region were contacted by
telephone, and information letters were posted out
to be given to their group members. As a result, the
study sample came from a number of areas across
the North East of England.
Materials
It is proposed that by obtaining a clearer under-
standing of the experience of living with epilepsy,
this may help put into context the experience of
making the withdrawal decision. As such, the inter-
view questions began by exploring the experience ofliving with epilepsy, before investigating the with-
drawal decision and the experience of withdrawal.
The questions began openly, regarding the effect
epilepsy has had on their lives, and leading to
specific areas of interest, such as medication and
family influences. Further questions were also
included during the interviews in order to explore
certain topics introduced by the participants.
Prior to the design of the interview questions, the
researcher used bracketing16 to suspend any pre-
conceptions regarding epilepsy, which may have
biased the responses of participants. Questions
could have been asked such as, ‘‘How has having
epilepsy affected your relationships with friends?’’.
In comparison, questions were used such as, ‘‘Do you
feel having epilepsy has affected you, and if so, in
what ways?’’. In this way, the participants were not
directed into talking about a subject which, may not
have been held as important to them.
Procedure
Before the interviews could begin, consent was
obtained from each participant. Permission was also
sought from participants regarding their interview
being audio taped. Each interview lasted between
30 min and 1 h, and took place either at people’s
homes, or in an office at one of the support group
centres. All interviews were carried out by the same
researcher, and recorded with the use of a dicta-
phone.
In order to improve the ‘‘credibility’’ of the
research, ‘‘participant validation’’17 was sought.
Confirmatory questions were asked throughout the
interviews in order to confirm the interpretations of
the participants’ responses made by the interviewer.
For example, if a participant reported problems with
their doctor, this may have inferred that this meant
they were dissatisfied with the support from their
doctor. In that case, they would be asked how satis-
fied they were with their doctor, as a means of
confirming (or correcting) this interpretation.
Following the ethical guidelines outlined by the
University of Teesside ethics Committee, any names
mentioned throughout the interviews were chan-
ged, as well as each participant being allocated a
participant number, in order to maintain anonymity.
At the end of each interview the participants
were debriefed, and provided with contact numbers
for NHS direct and support groups in their area (even
if they were already a member of a support group).
Analysis
Once the interviews were completed, they were
all transcribed verbatim, and a phenomenological
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guidelines set out by Lemon and Taylor.18
Firstly, each transcript was read and re-read in
order for the researchers to immerse themselves in
the data, and get a feeling for the information
which had been gathered. Secondly, significant
statements which described the experience of liv-
ing with epilepsy, the experience of medical sup-
port and the experience of making the decision to
withdraw from treatment and the withdrawal
itself, were extracted. The next stage in the ana-
lysis involved assigning meanings to each of these
statements.
Following this, the statements were grouped
together according to their meanings in order to
develop different themes. At this point, the
researchers referred back to the original transcripts
in order to make sure that the meanings assigned to
the statements were accurate when viewed within
the whole transcript. Finally, the themes were col-
lated, and the meanings of each theme were
reflected upon in order to develop a description
of the phenomena of discontinuing AED treatment
and the decision-making process.Results
Five themes emerged from the interviews (uncer-
tainty of the future; personal issues in making the
decision; it is ‘‘worth a try’’; G.P. support; accep-
tance).
Theme 1: uncertainty of future
Initial thoughts and feelings about discontinuing
medication were mixed. Participants noted the ben-
efit of not having to take AEDs anymore, but were
also concerned with the risk of seizure recurrence.
‘‘Mixed feelings . . . because yeah I was happy like
the thought of coming off them, being seizure free,
but its also . . . frightening to think oh but you’re
taking a risk that you still could possibly . . . like have
a seizure when you come off them’’.
‘‘. . . frightened whether, if it was going to happen
again was a big thing to me because loosing control
of what your doing . . . what your body’s actually
doing, you’re not aware of it . . . its quite frightening
so . . .’’
During the time when these participants still had
seizures, the uncertainty and speed of onset was
noted.
‘‘Why, one minute you’re alright and then the next
minute you’re bad . . . They just came on like that
(clicks fingers) Quick’’.The main concern with seizure recurrence
appears to be fear of loss of control during a seizure.
Following a seizure free period of 2 years or more, it
is daunting for someone to consider putting them-
selves at risk of losing control if a seizure was to
occur following withdrawal. Ultimately, however,
there is a recognition that there is just no way of
knowing if seizures will recur or not and they are left
to hope that the withdrawal will be successful.
‘‘. . . just . . . like just . . . like gonna hope, for the
best’’.
This issue of uncertainty of the future also con-
tinues following withdrawal. Although withdrawal
may be successful in the short term, there is no
agreed cut off point where people can be certain
that they will never have another seizure. In this
way the feelings of uncertainty continue from initi-
ally making the withdrawal decision, to well after
discontinuation of AEDs has occurred.
‘‘I would like to know how long before we can start
breathing’’.
Theme 2: personal issues in making the
decision
Although participants discussed a fear of seizure
recurrence, this theme highlighted more personal,
psychosocial issues which are also considered when
making the withdrawal decision. Three sub-themes
emerged from the data (embarrassment of diagno-
sis; medication problems; timing of withdrawal).
Sub-theme 1: embarrassment of diagnosis
The diagnosis of epilepsy was reported as embarras-
sing, affecting people’s confidence and self-esteem.
One participant even reported feeling ‘‘less of a
person’’ because of her epilepsy.
‘‘. . . in this day and age it isn’t really, like the
medication I take doesn’t make it a problem, I’m
able to drive and what have you, but its in my mind
that, I don’t know, I’m less of a person than what I
am . . .’’
‘‘. . . a little ashamed of it’’.
‘‘I felt embarrassed about being diagnosed with it
. . .’’
In turn, this influences the withdrawal decision in
that the hope of a successful withdrawal will take
away the label of epilepsy, helping the person to
become ‘‘normal’’ again. It is felt that not taking the
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epilepsy.
‘‘I just want it out of the way, so hopefully I don’t
have to say, put down on forms you’ve got epilepsy
. . . Yeah, so I’m normal
Sub-theme 2: medication problems
When asked about making the withdrawal decision
participants often discussed problems with their
medication, both in terms of their side effects
and the number of tablets they had to take each day.
‘‘I didn’t like it (MEDICATION) at first . . . there was
just too many of them’’.
‘‘. . . there is a lot of side effects . . . tremors, shaking
. . . poor concentration . . . erm, mood swings . . . erm
. . . change in appetite, change your erm sleeping
patterns’’.
Furthermore, one participant noted that despite
the fear of seizure recurrence, the side effects of his
AED medication outweighed the problems which
seizures caused for him.
‘‘. . . what I found was the side effect of the medica-
tion was worse than the seizures’’.
Additionally, a further medication issue was
noted by one participant who wanted to have a
child. She found she would have to withdraw from
her medication if she did become pregnant, as these
could harm the unborn child. This highlighted a
further consideration in the decision-making pro-
cess specifically for women.
. . . I read lots of articles that basically said it wasn’t
a good idea (TO GET PREGNANT) and if you could
possibly come off the medication then you should’’.
Sub-theme 3: timing of withdrawal
The timing of withdrawal was a key consideration in
the decision-making process both for the adults in
this study and the teenager.
‘‘And about 4 years ago we asked, just before he
started senior school because it would have been
nice, so if anything was going to happen he would
have still been in primary school when everybody
knew him . . .’’
Due to medical complications this first withdra-
wal did not take place, but the timing was still a key
consideration now as it would affect his opportunity
to learn to drive.‘‘. . . now we were at the stage of getting him off
them before he wants to learn to drive, ‘cos if he
had to go back on them, then you’re losing your
time’’.
However, the timing of discontinuing AEDs can
also stop the withdrawal process. It appears that
although the decision may have been made to with-
draw (based on issues such as embarrassment of
diagnosis, medication problems, etc.) if the timing
was not right, then the withdrawal would be
delayed or stopped completely.
‘‘. . . like I’m going on holiday and I’ve put off coming
off them again until I come back because I’ll have to
get watched in the swimming pool, and everything.
It means giving up my car for six months, and that
means a lot socially, how am I gonna . . . get about
and everything’’.
Theme summary
In summary, the withdrawal decision centres around
a number of psycho-social and medical issues, but
ultimately the timing of the withdrawal is para-
mount in the decision-making process. Although
participants reported having made the withdrawal
decision, based on their appraisal of embarrassment
at diagnosis and medication issues, the withdrawal
attempt could be delayed if the timing was inap-
propriate.
Theme 3: it is ‘‘worth a try’’
Once the issues noted in the previous themes had
been appraised, participants commented that it was
‘‘worth a try’’ to withdraw from their AED medica-
tion. After initial consideration of the impact and
uncertainty of seizure recurrence, the decision was
still made to ‘‘try’’ and discontinue their medica-
tion, providing the timing was right.
‘‘I suppose because I felt I’d gone so long without
any fits, so it was worth a try’’.
It is ‘‘worth’’ the risk of seizure recurrence in
some cases because this is seen as worse than con-
tinuing their medication — the benefits of not taking
AEDs outweighs the risk of seizure recurrence.
‘‘. . . you think well . . . OK it’s worth, worth a try, I’d
like to cos obviously . . . you don’t want to take them
(AEDs) for life or whatever’’.
However, the participants recognised that they
could only ‘‘try’’ to withdraw from their medication,
highlighting that there was no way of knowing if they
would be successful, and thereby stressing the uncer-
tainty of the situation, stating ‘‘I take it as it comes’’.
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When asked about the support they receive from
their G.P both for their epilepsy in general and in
making the withdrawal decision, there were mixed
responses. Both generally and in the decision-mak-
ing process, G.P.s did not appear to be providing
enough information for their patients or have refer-
ral systems in place for patients to get information
and support. In turn, patients were often left to
research the issue themselves without any support.
‘‘Erm . . . I think any finding out, I’ve probably done
myself’’.
‘‘I felt that there wasn’t er . . . enough information’’.
‘‘I askedmy consultant and he said yeah no problem,
as long as you’ve been, erm, seizure free for a year
on your medication, no problem . . . so . . . and there
was like no, he gave me no telephone help lines . . .
or anything like that’’.
As well as not providing adequate information,
G.P.s were perceived as having a poor knowledge of
epilepsy and were not up to date with research in
the area. This was particularly evident in the parti-
cipant who withdrew from her medication through
pregnancy. Despite approaching her G.P. before she
became pregnant, the information she received was
inaccurate.
‘‘. . . I’d actually gone and, you know in order to seek
advice as to what I should do before I got pregnant,
and was just given what I subsequently realise is
completely wrong advice’’.
‘‘if you get a G.P. that’s up to date on it, then fine,
but if you don’t, it’s a bit of a lottery’’.
On a positive note, one participant was happy
with the support she had received from her G.P. This
satisfaction appeared to be linked to the time and
support she had received. She was given time in the
consultation and her points were taken seriously. As
other participants noted the lack of knowledge
displayed by their G.P., this participant appeared
to recognise that her G.P. may not be an expert in
epilepsy, but allowed her to be the expert on her
condition and on how she felt rather than imposing
his/her own opinions on her and potentially provid-
ing inaccurate information.
‘‘I can say something and it’s never . . .well, ‘‘I’m the
doctor round here’’. But I talk to them, I put things
to them, and I say’’ look, if my body’s not right I can
feel it . . .’’Theme 5: acceptance
One participant who had three unsuccessful with-
drawal attempts discussed an acceptance of epi-
lepsy now, highlighting that an unsuccessful
withdrawal attempt was not necessarily detrimen-
tal to them in the long term. Although during the
decision-making process the participant reported
that it was worth the risk to try and discontinue
AED treatment rather than continuing to take med-
ication, with unsuccessful withdrawal this feeling
was eventually reversed.
‘‘I’d rather take it (MEDICATION) than have the
problems that seizures can cause’’.
‘‘Now, I would say I don’t want to. It’s just not worth
the risk’’.
Although initially the risk of seizure recurrence
was ‘‘worth’’ taking, the problems associated with
recurrent seizures ultimately changed the partici-
pant’s outlook. Interestingly she noted that she was
‘‘fortunate’’ that her seizures were well controlled
while on medication, yet this had not prevented her
from attempting to withdraw from the medication
initially.
‘‘. . . having had three spells where I’ve come off it
and had problems, erm . . . you just accept it, it’s
part of life, you know. But I suppose I’m fortunate
and it is pretty well controlled on medication . . .’’
Discussion
The themes presented highlighted a number of con-
siderations in the withdrawal decision. Initially feel-
ings were ‘‘mixed’’ as people recognised the
uncertainty of future seizure recurrence and consid-
ered the loss of control experienced during a seizure.
This was highlighted when considering their reports
of seizure occurrenceprior to the seizure free period.
Worry of when a seizure would occur promptedmany
of the participants to use techniques to ward off
future seizures. Some commented that they would
‘‘keep busy’’, and ‘‘self analyse’’ in an attempt to
keep further seizures at bay. However, such strate-
gies were performed in conjunction with taking their
AED medication, yet there was still ‘‘worry’’ as to
when thenext seizuremayoccur. In thisway, it canbe
seen how the prospect of not even taking medication
may be very daunting. Furthermore, for those who
hadsuccessfullywithdrawn, the fear of seizure recur-
rence continued since there was no agreed point
where they could be certain that they would never
have another seizure.
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Figure 1 Model of the decision-making process: Theory of Planned Behaviour.Despite this, the recognition that there was no
way of knowing if or when a seizure would occur, led
those making the withdrawal decision to consider
withdrawal and ‘‘hope for the best’’. However, more
personal issues were still to be considered in the
process. Participants discussed side effects of their
medication and the wish not to take drugs for the
rest of their lives, as well as the embarrassment of
having a diagnosis of epilepsy. The participants
reported feeling ‘‘less of a person’’ because of their
illness and may have attempted to conceal their
condition from others, in an effort to avoid the
embarrassment and shame of having epilepsy. Dis-
continuing AED treatment meant these people
would feel ‘‘normal’’ again. They might not view
themselves as having epilepsy anymore, and there-
fore need not conceal their condition or feel a sense
of shame at having epilepsy. This supports research
by Jacoby et al.5 who found that following discon-
tinuation of AED treatment, participants experi-
enced an increase in self-esteem.
A key concern in the withdrawal decision was the
timing of the withdrawal. It appears that once the
personal issues and seizure recurrence had been
considered, participants felt they would attempt
withdrawal. However, if the timing was not optimal,
the withdrawal would not go ahead. Ranganath and
Ramaratnam19 argue that the physician must deter-
mine speed and timing of withdrawal, however the
present results indicated people may have their own
timing criteria, such as starting school or University,
learning to drive and planning holidays. It is inter-
esting that the Medical Research Council Antiepi-
leptic Drug Withdrawal Study Group10 noted being
unable to drive as a factor in the decision for adults.
The current study has explored this further anddetermined that teenagers and younger adults
may consider timing of withdrawal as a crucial
element in the decision-making process.
Given that the timing of withdrawal was appro-
priate for the participants, they often reported
feeling withdrawal was ‘‘worth a try’’ and therefore
attempted it. There was again recognition of the
uncertainty of the future, expressing that they
would ‘‘try’’ to withdraw from their medication.
Despite the fear and uncertainty of seizure recur-
rence, the risk of withdrawal was worth taking.
However, for those who unsuccessfully withdrew
from AEDs there was an acceptance of seizures
and epilepsy. Initially the risk of recurrence was
worth taking, but following continued recurrence
there was an acceptance of the condition.
In terms of a model of the withdrawal decision-
making process, the following themes can be incor-
porated into the Theory of Planned Behaviour
(Fig. 1).12
Although this model has received much criticism
when applied to real life situations, in that intention
does not always lead to behaviour,20 as a model of
decision-making for AED withdrawal, intention or
the notion that it is ‘‘worth a try’’ always leads to
the decision to discontinue AEDs. With the inclusion
of ‘‘timing of withdrawal’’ this model could be used
to identify the issues of concern to those making the
withdrawal decision and the processes involved.
This particular factor also satisfies a further criti-
cism of the model, namely the disregard of imple-
mentation issues. Gollwitzer and Oettingen21 argue
that with the addition of implementation issues, the
model would consider a plan of how and when the
behaviour would be carried out and thus improve
the relationship between intention and behaviour.
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such a plan and thus improves the applicability of
the model to the AED withdrawal decision-making
process.
Despite the development of prediction cri-
teria7,22 there appears to be little support for peo-
ple making the withdrawal decision. The majority of
participants noted dissatisfaction with the informa-
tion they received from their G.P. and questioned
their knowledge of epilepsy. The Medical Research
Council Antiepileptic Drug Withdrawal Study
Group10 found no evidence of such support being
available for epilepsy sufferers who are eligible for
treatment withdrawal; little seems to have changed
in the intervening fifteen years. Furthermore, Per-
ucca et al.2 argue that G.P.’s should counsel their
patients who are making such a decision, especially
in regards of psychosocial issues, yet this support
seems lacking. Although NICE Guidelines23 advocate
consultants should oversee withdrawal from AEDs,
Smith and Chadwick1 and Smithson et al.24 note that
those with well controlled epilepsy may be referred
to their G.P. for future support and medication
advice, thus examining G.P. support in this area of
epilepsy care is important. However, due to the
potential complexities of withdrawing from medi-
cation, ideally, patients should be supported by both
their G.P. and their hospital consultant in this pro-
cess. The model identified in the present study
highlights the type of issues which people may need
support in considering, such as the timing of with-
drawal, the uncertainty of seizure recurrence and
the embarrassment of being labelled with epilepsy.
Although the nature of epilepsy means many of
these issues cannot be answered, by listening to
the concerns and experiences of those who have
gone through the withdrawal decision process we
may be able to support people in their consideration
of such factors. G.P.s or consultants could use this
model to guide their support or to refer people to
appropriate information services. The identification
of fear of seizure recurrence following a successful
withdrawal period also highlights the need for
ongoing support. However, this model should only
be used a guide for G.P.s or consultants as each
patient may have their own, individual concerns
about the withdrawal decision which should be
addressed.
However, there were a number of limitations with
the current study, such as the inclusion of people
from support groups. It is often argued that people
who attend support groups are those who experi-
ence more difficulties with their illness, and there-
fore may present a biased view of the condition
under investigation. However, the nature of being
eligible for withdrawal means these participantshad not experienced a seizure for at least 2 years,
so they will provide a more balanced account of the
experience of living with epilepsy and making the
withdrawal decision. Although some participants
were making the withdrawal decision at the time
of the interview, retrospective accounts from the
remaining participants may mean their recollec-
tions of events at the time of withdrawal are inac-
curate. In the future, perhaps a sample of people
making the withdrawal decision could be recruited
from G.P.s or consultants. This would also allow for
the opportunity to explore the decision-making pro-
cess for those who do not decide to withdraw from
their AED treatment. The current study is only
exploratory, with a distinct focus on the experience
of withdrawing from medication. Future research
could explore this phenomenon further, with a
larger sample, including those who decide not to
withdraw from treatment.Conclusion
By listening to the experiences of those making the
withdrawal decision, this study has uncovered a
number of key factors, which are inherent in the
decision-making process. Namely, consideration of
medication issues, the uncertainty of seizure recur-
renceand feelings of beingdiagnosedwithepilepsy. A
key concern appears to be the timing of withdrawal;
an issue which can delay the withdrawal attempt. In
turn, a model of these issues, based on the Theory of
Planned Behaviour,12 can be used to guide support for
those making the decision–—a service which at pre-
sent is poorly provided. Although exploratory, the
current study has highlighted the psychosocial impli-
cations of making the decision to discontinue med-
ication. Further investigation in this areamay inform
support provision for people faced with the decision
to withdraw from AED treatment.Acknowledgements
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